SYSTEMIC INFLAMMATION
Clinical trials for SYSTEMIC INFLAMMATION explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC INFLAMMATION trials appear
Sign up with your email to follow new studies for SYSTEMIC INFLAMMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Common diabetes drug tested to calm immune system in drug users
Disease control Recruiting nowThis study tests whether metformin, a common diabetes drug, can reduce harmful inflammation and improve immune function in 100 adults aged 18-64 who have a history of injection drug use, with or without HIV. Participants will take metformin or a placebo for 16 weeks and have thei…
Matched conditions: SYSTEMIC INFLAMMATION
Phase: PHASE4 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New drug aims to ease heart failure symptoms in inflamed patients
Symptom relief Recruiting nowThis study tests a new medicine called ziltivekimab in 680 adults with heart failure and signs of inflammation. Participants will receive either the drug or a placebo for up to 16 months. The goal is to see if the drug improves heart failure symptoms and physical function, like b…
Matched conditions: SYSTEMIC INFLAMMATION
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Jun 18, 2026 11:52 UTC
-
Fish oil and band workouts: a new hope against cancer muscle loss?
Symptom relief Recruiting nowThis study tests whether taking omega-3 fish oil capsules and doing simple resistance exercises with elastic bands can help cancer patients maintain muscle mass and strength. It involves 288 adults with various cancers who are at risk of muscle wasting. The goal is to improve phy…
Matched conditions: SYSTEMIC INFLAMMATION
Phase: NA • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Symptom relief
Last updated Jun 16, 2026 12:54 UTC
-
Scientists launch deep dive into mysterious inflammatory diseases
Knowledge-focused Recruiting nowThis study aims to understand the causes and progression of systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD) by observing up to 2,000 participants over time. Researchers will collect medical history, blood samples, and genetic data to identify …
Matched conditions: SYSTEMIC INFLAMMATION
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC